ENT Surgical Devices Market: Rising prevalence of ENT disorders is expected to drive the market

Global ENT Surgical Devices Market – Overview

ENT surgical devices are mainly used for diagnosing, treating, or doing surgery related to disorders concerning ear, nose, and throat. They help in clearing problems such as speaking, snoring, smelling, or hearing. There is wide range of ENT surgical devices available in the market. Rising prevalence of ENT disorders and preference towards minimally invasive surgeries is expected to drive the growth of the global market in the coming years of the forecast period.

Read Report Overview - https://www.transparencymarketresearch.com/ent-surgical-devices-market.html

Global ENT Surgical Devices Market – Notable Developments

Some of the prominent developments in the global ENT surgical devices market are given below:

  • In February 2018, Stryker Corporation announced the completion of acquisition Entellus Medical, a leading provider of minimally invasive medical technology of ENT disease states.
  • In May 2018, Johnson & Johnson’s Acclarent in collaboration with Bioscience Webster launched TruDi ENT navigation system with a real-time 3D navigation system.
  • In October 2018, Carl Zeiss Meditech AG announced the launch of TIVATO 700 and EXTARO 300 microscopes with improved visualization and enhanced workflow augmentation concept based on an all-digital approach for ENT procedures. 
  • In March 2018, Olympus Corporation launched ENF-VT3, the world’s first rhino-laryngo videoscope with an aim to incorporate 4-direction angulation capability.
  • In December 2017, Intersect ENT announced FDA approval of a new sinus implant SINUVATM which is an in-office treatment option for recurrent nasal polyps.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=80520

Some of the key players in the global ENT surgical devices market are Medtronic plc (Ireland), Olympus Corporation (Japan), KARLSTORZ GmbH & Co (Germany), Stryker Corporation (U.S.), Smith & Nephew plc (U.K.), Acclarent, Inc. (U.S.), Hoya Corporation (Japan), Sonova Holdings AG (Switzerland), William Demant Holdings A/S (Denmark), and Cochlear Limited (Australia)

Global ENT Surgical Devices Market – Drivers and Restraints

There are multiple factors that are expected to drive the overall development of the global ENT surgical devices market. One of the key driving factors for the market development has been the increasing prevalence of ENT disorders across the globe, particularly among pediatric population. ENT surgical devices marketplace covers a broad range of surgical instruments and equipment. Spurred by evolving demand trends and increased focus on health-based delivery model, technology integration has disrupted the medical devices landscape. In a way, ENT surgical devices market remains established wherein the dynamism is maintained by advanced technology integrations.

Request for Analysis of COVID-19 Impact on ENT Surgical Devices Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=80520

Another important factor for the development of the global market has been the increasing preference towards minimally invasive surgeries. Moreover, rapid developments in the field of medical technologies are also projected to help the development of the global market in the coming years of the forecast period.

Furthermore, the growing prevalence of ENT disorders have led to governments offering reimbursement support to patients. Favorable reimbursement policies are also likely to help the development of the global ENT surgical devices market in the coming years of the forecast period.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=80520

Global ENT Surgical Devices Market – Geographical Outlook

In terms of geographical segmentation, the global ENT surgical devices market is divided into five key regions. These regions are North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. Of these, currently the global market is being dominated by the regional segment of North America. Presence of a highly matured healthcare infrastructure is one of the key factors that is driving the growth of the North America market. In addition to this, presence of several notable players is also another factor that has been influencing the development of the North America market.

Pre Book ENT Surgical Devices Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=80520&ltype=S

On the other hand, the regional segment of Asia Pacific is expected to witness a highly promising rate of growth in the coming years of the forecast period. The growth of the market can be attributed to increasing demand from emerging economies such as India and China.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.


Mr. Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

Back to news